‚Dose-dense‘ chemo for premenopausal breast cancer patients improves survival

Premenopausal women with breast cancer have a better chance of survival if they are given cycles of adjuvant chemotherapy closer together, every two weeks rather than every three weeks. Furthermore, this regime does not increase the risk of early menopause, according to results of a meta-analysis of trials involving over 3,000 patients. (Mehr in: Cancer News — ScienceDaily)